Litcius/Paper detail

Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial

Milind Javle, Christos Fountzilas, Chih‐Yi Liao, Meredith S. Pelster, Daneng Li, Dustin A. Deming, Vaibhav Sahai, Lionel Aurelien Kankeu Fonkoua, Allen Lee Cohn, Parvez Mantry, Donald Richards, Edwin Kingsley, Frank Wu, Peng Peng, Katie Hennessy, Hui Wang, Caixia Sun, Shumao Ni, Jean Fan, Amit Mahipal

2025˜The œLancet. Gastroenterology & hepatology5 citationsDOI

Topics & Concepts

MedicineInternal medicinePhase (matter)OncologyClinical trialPhases of clinical researchDiseaseRadiation therapyMEDLINECancerCholangiocarcinoma and Gallbladder Cancer StudiesFibroblast Growth Factor ResearchLung Cancer Treatments and Mutations
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial | Litcius